个体化居家干预对创伤性脑损伤慢性期的影响:一项随机临床试验
这项在挪威东南部开展的意向性治疗、平行组、评估者盲法随机临床试验纳入120例TBI超过2年、居家且仍有TBI相关困难的成人,1:1随机接受4个月内8次个体化目标导向居家康复或常规照护。12个月时主要结局疾病特异性HRQOL(QOLIBRI总体评分:2.82;97.5%CI,-3.23至8.88;P=.30)和社会参与(PART-O社会子量表评分:0.12;97.5%CI,-0.14至0.38;P=.29)均无显著组间效应。12个月时干预组通用HRQOL(EQ-5D-5L评分:0.05;95%CI,0.002-0.10;P=.04)更高,TBI症状(RPQ总分:-3.54;95%CI,-6.94至-0.14;P=.04)和焦虑(GAD-7评分:-1.39;95%CI,-2.60至-0.19;P=.02)更少。4个月时干预组TBI相关问题管理困难更少(目标结局平均严重度评分:-0.46,95%CI,-0.76至-0.15;P=.003)。未报告不良事件。
要点
- 12个月时主要结局无显著组间效应:QOLIBRI总体评分2.82(97.5%CI,-3.23至8.88;P=.30),PART-O社会子量表评分0.12(97.5%CI,-0.14至0.38;P=.29)。
- 12个月时干预组(n=57)较对照组(n=55)通用HRQOL更高:EQ-5D-5L评分0.05(95%CI,0.002-0.10;P=.04)。
- 12个月时干预组较对照组TBI症状更少:RPQ总分-3.54(95%CI,-6.94至-0.14;P=.04);焦虑更少:GAD-7评分-1.39(95%CI,-2.60至-0.19;P=.02)。
- 4个月时干预组(n=59)较对照组(n=59)TBI相关问题管理困难更少:目标结局平均严重度评分-0.46(95%CI,-0.76至-0.15;P=.003)。
- 干预组接受4个月内8次个体化目标导向康复,对照组接受所在市常规照护;未报告不良事件。
适用人群与场景
- 挪威东南部成人,TBI超过2年,居家生活,且仍有TBI相关困难。
- 邀请基于人群的555人样本,最终纳入120人;中位(IQR)年龄47.5(31.0-55.8)岁,中位(IQR)伤后时间4(3-6)年,85人(70.8%)为男性。
处置流程与药物剂量
- 干预组:4个月内接受8次个体化、目标导向的康复项目,由专业康复治疗师在患者家中或通过视频会议和电话提供。
- 对照组:接受所在市的常规照护。
研究设计与关键结果
- 研究设计:意向性治疗、平行组、评估者盲法随机临床试验,1:1随机分组,于2018年6月5日至2021年12月14日收集数据。
- 主要结局:基线至12个月,疾病特异性HRQOL(QOLIBRI总体评分:2.82;97.5%CI,-3.23至8.88;P=.30)和社会参与(PART-O社会子量表评分:0.12;97.5%CI,-0.14至0.38;P=.29)均无显著组间效应。
- 12个月次要结局:干预组(n=57)较对照组(n=55)EQ-5D-5L评分高0.05(95%CI,0.002-0.10;P=.04),RPQ总分低3.54(95%CI,-6.94至-0.14;P=.04),GAD-7评分低1.39(95%CI,-2.60至-0.19;P=.02)。
- 4个月次要结局:干预组(n=59)较对照组(n=59)目标结局平均严重度评分低0.46(95%CI,-0.76至-0.15;P=.003)。
- 不良事件:未报告。
证据类型、等级与局限
- 证据类型:随机临床试验(RCT),意向性治疗分析,评估者盲法。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,康复干预可能帮助TBI慢性期患者,即使处于慢性期;但主要结局疾病特异性HRQOL和社会参与无显著改善。
- 对TBI慢性期居家患者,4个月内8次个体化目标导向康复可能改善通用HRQOL、TBI症状和焦虑,并维持至12个月;4个月时可能减少TBI相关问题管理困难。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Traumatic brain injury (TBI) can cause long-lasting and heterogeneous difficulties that require an individually tailored approach to rehabilitation. However, high-quality studies of treatment options in the chronic phase of TBI are lacking.
OBJECTIVE: To evaluate the effect of a home-based, individualized, and goal-oriented rehabilitation intervention in the chronic phase of TBI.
DESIGN, SETTING, AND PARTICIPANTS: This study was an intention-to-treat parallel-group assessor-blinded randomized clinical trial with 1:1 randomization to an intervention or control group. Participants included adults in southeastern Norway who had sustained a TBI more than 2 years earlier, lived at home, and had ongoing TBI-related difficulties. A population-based sample of 555 individuals were invited, and 120 were included. Participants were assessed at baseline, 4 months, and 12 months after inclusion. Specialized rehabilitation therapists provided the intervention in patients' homes or via video conference and telephone. Data collection was conducted between June 5, 2018, and December 14, 2021.
INTERVENTIONS: The intervention group received an 8-session individually tailored and goal-oriented rehabilitation program over 4 months. The control group received usual care in their municipality.
MAIN OUTCOMES AND MEASURES: Preestablished primary outcomes were disease-specific health-related quality of life (HRQOL; measured by the Quality of Life After Brain Injury [QOLIBRI] overall scale) and social participation (measured by the Participation Assessment With Recombined Tools-Objective [PART-O] social subscale). Preestablished secondary outcomes included generic HRQOL (measured by the EuroQol 5-dimension 5-level [EQ-5D-5L] questionnaire), difficulty with TBI-related problem management (target outcomes; mean severity calculated across 3 main self-identified problem areas that were individually measured using a 4-point Likert scale), TBI symptoms (measured by the Rivermead Post Concussion Symptoms Questionnaire [RPQ]), psychological distress (depression and anxiety; measured by the Patient Health Questionnaire 9-item scale and the Generalized Anxiety Disorder 7-item scale [GAD-7], respectively), and functional competency (measured by the Patient Competency Rating Scale).
RESULTS: Among 120 participants in the chronic phase of TBI, the median (IQR) age was 47.5 (31.0-55.8) years, and the median (IQR) time since injury was 4 (3-6) years; 85 (70.8%) were male. A total of 60 participants were randomized to the intervention group, and 60 were randomized to the control group. Between baseline and 12 months, no significant between-group effects were found for the primary outcomes of disease-specific HRQOL (QOLIBRI overall scale score: 2.82; 97.5% CI, -3.23 to 8.88; P = .30) or social participation (PART-O social subscale score: 0.12; 97.5% CI, -0.14 to 0.38; P = .29). At 12 months, the intervention group (n = 57) had significantly higher generic HRQOL (EQ-5D-5L score: 0.05; 95% CI, 0.002-0.10; P = .04) and fewer symptoms of TBI (RPQ total score: -3.54; 95% CI, -6.94 to -0.14; P = .04) and anxiety (GAD-7 score: -1.39; 95% CI, -2.60 to -0.19; P = .02) compared with the control group (n = 55). At 4 months only, the intervention group (n = 59) had significantly less difficulty managing TBI-related problems (target outcomes mean severity score: -0.46, 95% CI, -0.76 to -0.15; P = .003) compared with the control group (n = 59). No adverse events were reported.
CONCLUSIONS AND RELEVANCE: In this study, no significant results were observed for the primary outcomes of disease-specific HRQOL or social participation. However, the intervention group reported improvements in secondary outcomes (generic HRQOL and symptoms of TBI and anxiety) that were maintained at 12-month follow-up. These findings suggest that rehabilitation interventions could help patients even in the chronic phase of TBI.
TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03545594.
参考来源
- Borgen IMH, Løvstad M, Hauger SL, et al. Effect of an Individually Tailored and Home-Based Intervention in the Chronic Phase of Traumatic Brain Injury: A Randomized Clinical Trial. JAMA Netw Open. 2023. PMID: 37145600. doi:10.1001/jamanetworkopen.2023.10821
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。